Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. ORMP
ORMP logo

ORMP

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ORMP News

Analysis of High Dividend Stocks in Healthcare Sector

1d agoseekingalpha

Lifeward Announces 1-for-12 Reverse Stock Split

Feb 20 2026stocktwits

Oramed Pharmaceuticals and Lifeward Sign Strategic Deal, Investing $9 Million

Jan 13 2026NASDAQ.COM

Oramed Pharmaceuticals Receives $18 Million Payment, Declares $0.25 Dividend

Jan 07 2026Newsfilter

ORAMED PHARMACEUTICALS INC. ANNOUNCES DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS AS DIVIDEND

Nov 17 2025Newsfilter

Oramed Reports Fiscal Third Quarter 2025 Financial Results

Nov 17 2025PRnewswire

Oramed Shares Update with Shareholders on Oral Insulin Program Progress, Notable Investment Gains, and Future Growth Plans

Oct 23 2025Newsfilter

Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical

Apr 28 2025Newsfilter

Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals

Apr 28 2025Newsfilter

Oramed Pharmaceuticals invests $36.9 M in Alpha Tau Medical

Apr 28 2025SeekingAlpha

Alpha Tau Closes $36.9 Mln Offering And Forms Strategic Alliance With Oramed Pharmaceuticals

Apr 01 2025NASDAQ.COM

Oramed Pharmaceuticals Issues Letter to Shareholders

Mar 04 2025PRnewswire

Oramed's New OraTech Venture Aims To Revolutionize Diabetes Care With Oral Insulin Delivery

Feb 11 2025NASDAQ.COM

Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin

Feb 11 2025Newsfilter

Scilex Holding Company Announces Early Installment Payment on its Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation

Dec 16 2024Newsfilter

Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt

Oct 07 2024Newsfilter